Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

Clinical trial NCT05441904 · COMPLETED

Trial details

NCT number: NCT05441904
Sponsor: Poxel SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-03-08
Primary completion: 2021-03-29
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.